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Background: Since 1999, field evidence of transplacental infection by porcine circovirus type 2 (PCV2) and
reproductive failure has been reported in pigs. The objective of this study was to evaluate the clinical and
pathological consequences of PCV2 infection in conventional PCV2-seropositive gilts by insemination with
PCV2b-spiked semen.
Results: Six PCV2 seropositive gilts were inseminated with PCV2b-supplemented semen (infected) and three
animals with semen and cell culture medium (controls). Only three out of the six infected animals were pregnant
by ultrasonography on day 29 after insemination, while two out of the three controls were pregnant. One control
gilt aborted on day 23 after insemination but not due to PVC2. Viraemia was demonstrated in four out of six
infected and in one control gilt that became infected with PCV2a. Anti-PCV2 antibody titres showed dynamic
variations in the infected group throughout the study. Among infected gilts, the animal with the lowest anti-PCV2
titre (1/100) at the beginning of the experiment and another that reached a similar low value during the
experiment showed evident seroconversion over time and had also PCV2 positive foetuses. One placenta displayed
mild focal necrosis of the chorionic epithelium positively stained by immunohistochemistry for PCV2 antigen.
Conclusions: PCV2-seropositive gilts can be infected with PCV2 after intrauterine exposure and low maternal
antibody titre may increase the probability of a foetal infection.
Keywords: Swine, Porcine circovirus type 2, Semen, InfectionBackground
Porcine circovirus type 2 (PCV2)-related conditions
cause economic losses to the pig industry around the
world. Apart from post-weaning multisystemic wasting
syndrome (PMWS), PCV2 is associated with a number
of conditions collectively known as porcine circovirus
diseases (PCVD) [1-6].
Recently, a new line of studies have focused on PCV2-
associated reproductive failure, including irregular return
to oestrus, failure of pregnancy progressing to abortion,
or reduced litter size with PCV2 being detected in* Correspondence: carlo_blanc@yahoo.it
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reproduction in any medium, provided the oraborted and stillborn foetuses [7-9]. Although the main
route of PCV2 transmission is thought to be faecal-oral
[10], some studies have speculated on the role of artificial
insemination, even though this route has never been
proved [11,12]. Transplacental spread of PCV2 has been
demonstrated [13,14] and the vertical transmission of
PCV2 to conceptuses is found to be due to a prolonged
viraemia in pregnant sows with low anti-PCV2 antibody
titre [15,16]. Materno-foetal transmission can occur via
free viral PCV2 particles or cell-mediated viraemia [13].
Prolonged duration of PCV2 viraemia in the sow seems
to increase the probability of vertical transmission
[14,15].
The role of viraemia was also implicated by Mateusen
and others [16] who proved that exposure to PCV2. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sarli et al. Acta Veterinaria Scandinavica 2012, 54:51 Page 2 of 9
http://www.actavetscand.com/content/54/1/51during the earliest stages of embryonic development
with an intact zona pellucida (ZP) did not cause infec-
tion. On the contrary, blastocyst exposure after the ZP
phase led to immunolabelling of PCV2 in placenta,
mesonephros and neural groove of viable and non-viable
embryos, the latter showing a stronger positivity [16].
The virus can also be isolated not only in semen but also
in oocytes of infected sows [17-20] and can be also
transmitted to the conceptus as a consequence of genital
tract affection [19].
To date, several studies have investigated the role of
PCV2 in experimental infection of pregnant swine such
as surgical trans-uterine viral inoculation [21,22], oro-
nasal infection of specific pathogen-free (SPF) [18] or
seronegative conventional sows [14], insemination with
PCV2-spiked semen of PCV2 seronegative or SPF sows
[15,23,24], whereas investigations employing the intra-
uterine route with infected semen in conventional PCV2
antibody-positive sows are lacking. The available litera-
ture mainly describes foetal lesions in PCVD reproduct-
ive pathology and the distribution of PCV2 in the genital
tract, oocytes and embryos, but uterine or placental
lesions are poorly or not documented. In addition,
Madson and others [15] suggest persistent infection
could increase the probability of vertical transmission to
foetuses, reporting that experimentally infected PCV2
seronegative sows gave birth to polymerase chain reaction
(PCR)-positive live-born piglets with detectable serum
anti-PCV2 antibodies in the presuckling state, attributable
to in utero PCV2 transmission. Therefore, the objective of
this study was to evaluate infection of unvaccinated
PCV2-seropositive gilts with artificially PCV2-infected
semen. The interferences exerted by PCV2 from days 0 to
55 of pregnancy were also evaluated.
Methods
Statement of animal care
The experimental procedures were approved by the Ani-
mal Experimentation Ethical and Scientific Committee -
Alma Mater Studiorum of the University of Bologna and
subsequently submitted to and approved by the Italian
Ministry of Health. The study was carried out in accord-
ance with European legislation regarding the protection
of animals used for experimental and other scientific
purposes (Council Directive 86/609/EEC).
Animals
Nine healthy prepubertal, conventional, six-month-old,
Large White gilts (96.4 ± 4.3 kg body weight) were pur-
chased from a local PCV2-infected breeding farm and
allowed to acclimatise for five days; a Large White boar
was obtained from the Veterinary Faculty stable facility.
The gilts had been vaccinated with an inactivated gE-
deleted vaccine against Aujeszky’s Disease virus (ADV)and Porcine Parvovirus (PPV) as instructed by the leaf-
let. The animals were numbered by ear tags and ran-
domly divided into two groups: an infected group (six
animals: I1, I2, I3, I4, I5, I6) and a control group (three
animals: C1, C2, C3). The groups were housed in separate
rooms where each gilt was kept in an individual 5.5 m2
box equipped with an individual water nipple and feeding
trough. Gilts were fed twice a day 2 kg/day/animal of a
balanced ration especially formulated for gestation. Du-
ring feeding, rectal temperature and clinical appearance
was recorded. All personnel entering the rooms used
disposable protective clothing.
Virus
The virus used was a PCV2b strain isolated from an out-
break of PMWS in Italy and genotyped as reported by
Hesse and others [25]. It was propagated in circovirus-
free PK15 cells and its identity was confirmed by PCR
analysis and reactivity with specific PCV2 monoclonal
antibodies. The viral suspension titre was determined by
growing serial dilutions in circovirus-free PK15 cell
monolayers, followed by immunofluorescent labelling
for viral antigen.
Semen processing
A sperm-rich fraction of ejaculate was collected by gloved
hand technique from a Large White mature boar, evalu-
ated for motility, morphology and concentration by mi-
croscopy, and extended in equal volumes of AndrohepTM
(Minitub, Tiefenbach, Germany). The semen was tested
by real-time PCR (RT-PCR) to rule out any PCV2 DNA
[25]. To evaluate a potential negative effect of viral sus-
pension on sperm quality, viability and motility were ana-
lyzed before and after mixing with viral suspension.
Viability was assessed with a live/dead sperm viability kit
(Molecular Probes, Inc., Eugene, OR, USA) and at least
200 spermatozoa per sample were scored with a Nikon
Eclipse E 600 epifluorescence microscope (Nikon Europe
BV, Badhoeverdop, The Netherlands). The percentage of
overall motile spermatozoa was subjectively evaluated
using a pre-warmed glass slide under a contrast-phase
microscope at 400× magnification. Nine standard doses
(3× 109 spermatozoa/100 ml) were prepared in Andro-
hepTM; six doses containing 10 ml of viral suspension
(103.9 TCID50/ml PCV2; total viral dose: 10
4.9 TCID50) in
minimal essential medium (MEM) and three doses 10 ml
of MEM (control, sham dose); the infectious dose of
PCV2b used was similar to doses used elsewhere [15].
Doses were then incubated for one hour at room
temperature before artificial insemination (AI).
Experimental design
The day of artificial insemination (DAI) was set to day 0.
The animals were treated with 1500 IU/gilt of equine
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Netherlands) on DAI −4 and 60 h later (i.e. DAI −2) with
750 IU hCG (CorulonW, Intervet, the Netherlands), both
intramuscularly (IM), to induce oestrus synchronization
and superovulation. Forty hours later (i.e. on DAI 0), the
gilts manifested glaring standing reflex to man, and were
artificially inseminated once with a standard semen dose
[26] utilizing sterile Melrose catheters: six gilts were inse-
minated using semen mixed with the viral suspension (as
above) and three control gilts using semen supplemented
with 10 ml of MEM to obtain sham control semen doses.
Approximately at DAI +20-21 and subsequent days, ani-
mals were examined to evaluate oestrus signs. At DAI
+29, ultrasound was performed to determine if the gilts
were pregnant. Empty subjects (C2, I5, I3 and I6)
underwent pharmacological euthanasia after anaesthesia,
whereas the pregnant animals were euthanized on DAI
+52 (C3), +55 (I1 and I2) +56 (C1 and I4). The pharmaco-
logical protocol adopted for euthanasia was: 1) 8 ml of
StresnilW (Janssen Animal Health, Beerse, Belgium) IM; 2)
25 ml of Ketavet100W (Intervet Productions S.r.l., Milan,
Italy) IM after 20 min.; 3) 10 ml of 50 mg/ml pentothal
sodiumW (Intervet Productions S.r.l., Milan, Italy) intra-
venously (IV) after 20 min. 4) and 10 ml TanaxW (Intervet
Italia, Latina, Italy) IV.
In vivo samplings
Vaginal, nasal and rectal swabs, and blood samples
were collected from all gilts prior to PCV2 infection,
on DAI −2 and then weekly thereafter until DAI +52.
The serum obtained was stored at −20°C until assess-
ments. Blood samples were not collected at DAI +14
so as not interfere with the maternal recognition of
pregnancy (13–18 days).
Progesterone serum evaluation
Serum progesterone (P4) was analysed by validated
radioimmunoassay as previously described [27] to deter-
mine pregnancy before ultrasonography on DAI +28.
Briefly, aliquots of 200 μl were extracted with 5 ml pet-
roleum ether. After centrifugation, ether was collected
and dried under a N2 stream. Dried ether extracts were
resuspended in 1 ml phosphate buffer and aliquots of
100 μl were then assayed. The sensitivity of the assay
was 1.0 pg/tube. The intra- and inter-assay coefficients
of variation were 6.3 and 8.6%, respectively. The results
are expressed as ng/ml.
Serology
Serum antibody titres to PCV2, PPV, ADV and porcine
respiratory and reproductive syndrome virus (PRRSV)
were determined by testing serial dilutions of each
serum. Antibodies to PCV2 were detected by an in-
house competitive ELISA based on monoclonal antibodiesagainst PCV2 [28]. Tenfold dilutions of the sera from 1/10
to 1/10000 were tested and the highest dilution giving at
least a 75% inhibition of the control reaction was consid-
ered PCV2 positive. PPV antibodies were determined by
testing fourfold dilutions (from 1/4 to 1/256) of each
serum with an in-house competitive ELISA performed
using the neutralizing monoclonal antibody (MAb)
3C9D11H11 from ATCC (ATCC number CRL 1745). The
serological analyses to ADV were performed by two
MAb-based in-house competitive ELISAs for anti-gB and
anti-gE antibody detection [29]. PRRSV antibodies were
detected by a competitive ELISA using a monoclonal anti-
body reactive for N-protein [30].
Serum antibody titres to PCV2 were determined
weekly (from DAI −2 to date of euthanasia), whereas
antibodies against PPV, ADV and PRRSV were deter-
mined at DAI −2 and at the date of euthanasia.
Real–time polymerase chain reaction
Viral DNA obtained from swab, sera, seminal plasma and
tissues was isolated using Trizol Reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions. The blood samples underwent RT-PCR for
PCV2 following the protocol described by Olvera and
others [31]. In addition, PRRSV, PPV and ADV genomes
were tested for each blood sample by methods described
by Bonilauri and others [32], Katz and Petersen [33], and
Kim and others [34], respectively. No PPV, PRRSV and
ADV genome were proved in swab and blood samples
during the trial.
PCV2-PCR for DNA sequencing
Total DNA was extracted from both the samples and
viral stocks using a QiaAmp DNA Mini-Kit (Qiagen,
Hiden, Germany) according to the manufacturer’s
instructions. Amplification was carried out following the
method proposed by Ouardani and others [35], incorp-
orating forward and reverse primers ORF.PCV2.S4 and
ORF.PCV2.AS4, respectively. The oligonucleotide set
was designed to permit the amplification of a 493 bp
long DNA fragment on the ORF-2 of PCV2 only. To
confirm the same PCV2 strain used for infection, an
additional PCV2a/PCV2b PCR was run on positive sam-
ples according to [25]. The PCR products were in both
cases electrophoresed on a 2% agarose gel and visualized
under ultraviolet light after staining with GelRed (Bio-
tium, Hayward, CA, USA).
To confirm that the PCV2 detected in samples of
infected animals was the strain used for infection, DNA
sequencing was performed both on the PCV2 strain
used for infection (positive control) and on the PCV2
DNA amplified by RT-PCR from positive cases. Prior to
submission to the automated reaction to Eurofins MWG
Operon, amplified products were cleaned up using a
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Germany). The sequences were analysed directly on the
amplicons that were first aligned and then compared
with known sequences present from NCBI GenBank
(http://www.ncbi.nlm.nih.gov) [36].Post mortem sampling
Gross lesions were evaluated in the gilts and the follow-
ing tissues were collected: tonsil, superficial inguinal,
mesometrial and tracheo-bronchial lymph nodes, ileum,
spleen, liver, kidney, ovary, salpinx, uterus, cervix, va-
gina, lung, and heart. All foetuses were numbered. From
each foetus, amniotic fluid, allantochorion and adjacent
endometrium, liver, spleen, and heart were collected.
Aliquots of the sampled tissues were used for RT-PCR,
histology and immunohistochemistry. During these pro-
cedures, sterilized instruments were changed between
litters and each foetus to avoid cross-contaminations of
samples.
Histopathology and immunohistochemistry
Tissue samples were fixed in 10% buffered formalin, paraf-
fin-embedded, and routinely stained with haematoxylin
and eosin (HE). Immunohistochemistry (IHC) was per-
formed using a PCV2 monoclonal antibody (PCV2 Mab
F217) as previously described by Sarli and others [37], but
using a streptavidin-biotin-peroxidase polymeric com-
plex (SuperPicture kit peroxidise, ZymedW Lab, San




















Figure 1 Progesterone (P4) serum levels in individual gilts. Levels of P
pregnant gilts.Results
Sperm quality was not affected by the treatment with
viral suspension. Overall motility and viability were both
very high in control and viral exposed spermatozoa (re-
spectively: 80.0% and 79.2% in control semen; 80.0% and
69.9% in exposed semen). In all the animals except C3
and I6, the P4 titre at DAI −2 was undetectable, but
40 h after CorulonW administration, only C3, which
showed oestrus signs when synchronization started, did
not display an evident cycle. Visible oestrus signs after
AI were observed only in C3 DAI +15, when the animal
was inseminated again. In this subject the day of the sec-
ond insemination was considered DAI 0. At DAI +23,
C2 aborted and three entire embryos were found on the
box floor. At DAI +29, ultrasound proved pregnancies in
five gilts: I1, I2, C1, I4, and C3. The three non-pregnant
gilts (I3, I5, and I6) had not shown oestrus signs since
DAI +21 but abortion had not been observed. As shown
in Figure 1, gilts I3 and I5 did not show any variation in
P4 titre up to DAI +42 and +28, respectively (oestrus
was not observable before these time points) whereas P4
increased in gilt I6 after DAI +35 proving a previous si-
lent oestrus ranging from DAI +35 to +42.In vivo results
At DAI −2, none of the gilts had viraemia for any of the
tested viruses. Eight out of nine animals showed a higher
anti-PCV2 antibody level at DAI −2 (range: 1/100 to 1/
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I1 16 1/102 21 and 35 - + + + - 10}/16 - 8*** 1
I2 11 1/103 - - - - - - - 1/11 - -





I3 0 1/104 7 + - + n.a. - - / - -
I5 0 1/104 28 - - - - + - / - -
I6 0 1/103 - - - - n.a. - - / + -
Control
gilts
C1 11 1/103 21 and 35}} - - - - - - - - -
C2 0 1/104 - - - - - - - / - -





* serum titres at the beginning of the experimental study.
** Days post artificial insemination/s of sampling when viraemia was recorded.
*** out of the 16 uterine tract samples, each corresponding to a foetus, 8 were PCV2 positive by PCR, but only in 7 cases there was concordance of the positive PCR result in both foetus and corresponding
endometrium.
} a foetus and its placenta were IHC positive, as well.
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infected animals (I1, I3, I4, I5) in a +7 to + 35 DAI time
range (Table 1). Gilt I1, with a low PCV2 antibody titre,
had viraemia on DAI +21 and +35. For all PCV2 DNA
positive sera, the viral load ranged from 1.10 × 103 to
1.56 × 104 PCV2 genome copies/ml. During the study
only one faecal-positive swab (2.93 × 103 PCV2 genome
copies/ml) was found and obtained from gilt I1 on DAI
+35. Analysis of the sequences detected in the infected
group confirmed the identity of the amplified region of
PCV2b used in the experimental infection and the virus
subsequently isolated in the positive cases, showing 99%
homology. Among the control subjects, only gilt C1 pro-
vided two viraemic blood samples on DAI +21 and +35.
The sequencing of PCV2 DNA detected in gilt C1
demonstrated that it was a PCV2a strain.
Anti-PCV2 antibody titre declined after DAI +7 fol-
lowed by a plateau in the controls. The anti-PCV2 anti-
body titre showed non-synchronous seroconversion in
four (I1, I2, I3, I6) out of the six infected animals result-
ing in a slight dynamic variation of antibody at the
group level (Figure 2). Gilt I1 with the lowest anti-PCV2
titre (1/100) at the beginning of the experiment and an-






















































Figure 2 a: Mean and individual anti-PCV2 antibody titres in inoculat
control gilts (CG).experiment, showed clear seroconversion over time and
they also had PCV2 positive foetuses.
Serum antibody titres to PPV, PRRSV and ADV
decreased between DAI −2 and at the last DAI (data not
shown). These results suggest that no accidental infec-
tion with PPV, PRRSV and ADV occurred during the
trial.Necropsy and post mortem results
The only lesions recorded included mild to moderate
chronic fibrous pleuritis in four animals (I2, C1, C2, I5)
and pericarditis in three gilts (I2 and C2 mild chronic fi-
brous and C3 slight serous pericarditis, respectively).
One animal showed bilateral cranioventral broncho-
pneumonia (I4). One case with mild serofibrinous peri-
tonitis (I3) and two with moderate multifocal interstitial
hepatitis (white spotted liver) were observed (I5, C3).
Three subjects displayed multifocal erosions in the
stomach. The only uterine changes observed were mu-
cosal congestion and oedema (gilts C2 and I6).
Gilts I1, I2, I4, C1, and C3 had 16, 11, 7, 11 and eight
fetuses, respectively, with length and weight within nor-















ed gilts (IG). b: Mean and individual anti-PCV2 antibody titres in
Figure 3 Histological and immunohistochemical changes in the placenta of a PCV2b-infected porcine foetus. a: Coagulation necrosis of
trophoblasts. Haematoxylin and eosin, Obj. 40x. b: Immunohistochemical staining of PCV2b antigen in trophoblasts. Diaminobenzidine
chromogen and haematoxylin counterstain, Obj. 40x. Photographs represent serial sections of a lesion with intralesional immunopositivity for
PCV2 antigen.
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not observed.
Several tissues from infected animals were PCV2-
positive (Table 1) with a viral load ranging from
1.01 × 103 to 5.40 × 106 PCV2 genome copies/ml. Pla-
centa and foetus no. 16 of gilt I1 displayed the highest
value of PCV2 genome copies/ml (4.01 × 108). In the
same gilt, the highest concomitance of PCV2 in both
foetus and the corresponding uterine tract (8 out of 10)
was recorded (Table 1). No gross or histopathological
changes were identified and PCV2 was not detected by
RT-PCR in the three aborted foetuses of the control gilt
C2. Sequence analysis of the amplified region of PCV2
used for the insemination was the same as that isolated
from tissues of infected animals.
Immunohistochemistry showed a weak cytoplasmic
positivity for PCV2 in only one placenta positive for
PCV2 DNA with the highest viral load (>108/ml) with
focal necrosis of the chorionic epithelium (Figure 3).
The same foetus had an IHC-PCV2-positive reaction in
the cytoplasm of hepatocytes after staining of liver sec-
tions.
Discussion
Although the conditions created in this trial are experi-
mental with a small number of animals, they reflect the
situation recently described in a breeding sector of a pig-
gery [39] in which 18.2% of tested semen were PCV2-
positive. A field condition with intrauterine PCV2 inocu-
lation, such as that occurring with contaminated semen
[20], was investigated employing conventional gilts. The
wide range in anti-PCV2 antibody titres of gilts in thisstudy probably reflects the serological situation in a con-
ventional herd.
The inoculation was successful: viraemia was recorded
in four out of six inoculated gilts although weekly sam-
pling is insufficient to identify viraemic phases in detail.
More frequent sampling would probably have identified
viraemia in more animals, e.g. in gilt I2 that had a PCV2
positive foetus and therefore had become infected. The
anti-PCV2 antibody titre showed dynamic variations in
infected subjects whereas a decline in anti-PCV2 anti-
body titre occurred after DAI +7 followed by a plateau
in the controls. Although we cannot completely rule out
that the virus shed by the viraemic gilts may have been
transmitted to other gilts, the few viraemic events and
the biosecurity measures adopted make this risk min-
imal. All control gilts became pregnant but gilt C2
aborted on DAI + 23, but without trace of PCV2b infec-
tion. Three out of six inoculated animals did not become
pregnant but showed no signs of a subsequent oestrus.
The plasma concentration of progesterone in gilt I6 at
DAI −2 showed that the gilt had already ovulated, while
gilts I3 and I5 had an optimal endocrinological status
for fertilization, similar to that of the other subjects.
The lack of pregnancy and the simultaneous infection
(viraemia) in both subjects could involve PCV2 and its
possible role in embryonic death.
Only the infected gilt with low PCV2 antibody titre at
DAI −2 (I1) showed concomitant viraemia and faecal
virus excretion. Presumably, the uterus is not a target
organ and after transient replication in the uterus, PCV2
reaches the lymphoid organs and viraemia ensues. These
viraemic episodes are the major source of foetal infec-
tion [40]. The spread of the virus to lymphoid tissues
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PCV2 antibody titres. Because most of the foetal expos-
ure to virus occurs after a maternal viraemic episode,
antibody levels play a role in reducing the amount of
virus that can cross the placenta [14,15]. Furthermore,
other studies [40,41] imply that anti-PCV2 antibodies
seem to be a partial safeguard against in utero PCV2 in-
fection. The present investigation also suggests anti-
PCV2 antibodies play a role in foetal protection even in
the case of a primary intrauterine infection. Gilt I1,
which showed the lowest anti-PCV2 titre at the begin-
ning of the experiment and gilt I2 that reached the same
antibody level at DAI +7, had PCV2b positive foetuses.
It is known that intra-uterine exposure of foetuses to
PCV2 does not produce infection in all of them and
when spread occurs adjacent foetuses are usually
affected [10,13,22,23]. The longer the infection lasts, the
higher the probability of virus transmission [21]. The
present results suggest that the proportion of foetuses
infected by vertical transmission depends on the mater-
nal antibody titre. The introduction of virus by semen is
not the prime cause of viral exposure of the conceptus
as long as the ZP protects it from PCV2 infection [16],
but it is important for the development of a viraemia
under which the foetuses become infected. This was
confirmed by Madson and others [15] who showed that
infection by artificial insemination can produce PCV2-
seropositive piglets. The low antibody level can also in-
fluence the number of infected foetuses as indicated by
the concomitant presence of PCV2 in both the foetuses
and the corresponding uterine tract (Table 1).
The results demonstrate that PCV2 not only replicates
in the foetus itself [7,8,13,14], but also in the chorionic
epithelium where it probably causes focal necrosis. If
sufficiently severe, placental lesions can cause foetal
death, and replication in the placenta may expose the
foetus to increased amounts of virus. These conditions
may lead to stillbirth, mummification or abortion as
observed under field conditions.Conclusions
This study supports the hypotheses that PCV2-seropositive
gilts can be infected with PCV2 after intrauterine exposure
and that a low maternal antibody titre may increase the
probability of foetal infection.Competing interests
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